세계의 세포외 매트릭스 시장 : 컴포넌트 유형별, 용도별, 원료별, 최종 사용자별, 제품 유형별, 기술별, 치료 영역별, 기능별, 생체 재료 유형별, 최종 이용 산업별, 지역별

Extracellular Matrix Market, By Component Type, By Application, By Source, By End-User, By Product Type, By Technology, By Therapeutic Area, By Function, By Biomaterial Type, By End-Use Industry, By Geography

US $ 4,500 ￦ 6,286,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 7,000 ￦ 9,778,000

PDF (Multi User License)

PDF 보고서를 동일 사업장에서 7명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000 ￦ 13,969,000

PDF (Enterprise User License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세포외 매트릭스 시장은 2025년에는 4,420만 달러로 평가되었고, 2032년에는 7,480만 달러에 이를 것으로 예측되며, 2025년부터 2032년까지의 CAGR은 7.8%를 보일 것으로 예측됩니다.

분석 범위		분석 상세
기준 연도	2024년	시장 규모(2025년)	4,420만 달러
실적 데이터	2020-2024년	예측 기간	2025-2032년
예측기간 CAGR(2025-2032년)	7.80%	예측 금액(2032년)	7,480만 달러

세포외 매트릭스(ECM)은 조직과 장기 내 세포에 구조적 지원을 제공하는 단백질과 탄수화물의 복잡한 네트워크를 의미합니다. ECM은 세포 부착, 이동, 증식, 분화 등 세포 행동을 조절하는 데 중요한 역할을 합니다. 또한 성장 인자와 사이토카인의 저장고로 작용하여 다양한 세포 과정에 영향을 미칩니다.

전 세계 세포외 매트릭스 시장은 만성 질환의 증가, 재생 의학에 대한 수요 증가, 조직 공학 분야의 기술 발전으로 인해 급속히 성장하고 있습니다. 이 시장은 만성 질환에 더 취약한 고령 인구 증가에 의해 주도되고 있습니다. 심혈관 질환, 정형외과 질환, 피부 궤양 등 만성 질환의 발생률이 높아지고 있기 때문입니다. 또한 수술 건수의 증가와 효과적인 상처 치유 솔루션에 대한 수요가 ECM 제품 수요를 촉진하고 있습니다.

그러나 ECM 기반 치료법의 높은 비용, 엄격한 규제 요건, 제한적인 보험 적용 정책 등이 시장 성장의 장애물로 작용하고 있습니다. 또한 의료진과 환자들의 ECM 기반 제품의 이점에 대한 인식 부족도 시장 성장을 저해하고 있습니다.

그럼에도 불구하고 시장에는 혁신적인 ECM 기반 제품 개발, 학술 기관과 산업계 간의 협력, 신흥 시장에서의 제품 포트폴리오 확장 등 성장 기회가 존재합니다. 또한 개인화 의학에 대한 관심 증가와 ECM 기술의 다른 고급 치료법과의 통합은 시장 확장 가능성을 높이고 있습니다.

결론적으로, 전 세계 세포외 매트릭스 시장은 만성 질환의 증가와 재생 의학에 대한 수요 증가로 인해 향후 몇 년간 상당한 성장을 기록할 것으로 예상됩니다. 그러나 높은 비용과 인식 부족과 같은 과제를 해결해야 시장 잠재력을 완전히 실현할 수 있을 것입니다.

시장 역학 :

세계의 세포 외 매트릭스 시장은 만성 질환의 증가, 조직 공학의 발전, 재생 의학에 대한 수요 증가 등 여러 요인에 의해 주도되고 있습니다. 만성 질환에 더 취약한 고령 인구의 증가가 시장 성장의 주요 촉진요인입니다. 또한 수술 건수의 증가와 효과적인 상처 치유 솔루션에 대한 수요가 엑스트라셀룰러 매트릭스 제품 수요를 촉진하고 있습니다.

그러나 시장은 ECM 기반 치료법의 높은 비용, 엄격한 규제 요건, 제한적인 보험 적용 정책 등 여러 도전 과제에 직면해 있습니다. ECM 기반 치료법의 높은 비용은 시장 성장의 주요 장애물로 작용해 더 많은 환자가 접근하기 어렵게 만들고 있습니다. 또한, ECM 기반 제품의 승인에 대한 엄격한 규제 요건과 일부 지역의 제한적인 보험 적용 정책은 시장 확장을 방해하고 있습니다.

이러한 도전 과제에도 불구하고 시장은 성장 기회를 다수 보유하고 있습니다. 생체활성 스캐폴드와 조직 공학 구조물과 같은 혁신적인 ECM 기반 제품의 개발은 시장 확장에 큰 잠재력을 지니고 있습니다. 학술 기관과 산업계 간의 협업은 혁신을 촉진하고 고급 ECM 기술 개발을 가속화할 수 있습니다. 또한 재생 의학 수요가 증가하는 신흥 시장에서 제품 포트폴리오를 확장하는 것은 새로운 성장 기회를 열어줄 수 있습니다.

결론적으로, 세계의 세포외 매트릭스 시장은 만성 질환의 증가와 재생 의학에 대한 수요 증가 등 다양한 요인에 의해 주도되고 있습니다. 그러나 높은 비용과 규제 요건과 같은 도전 과제는 해결되어야 하며, 혁신과 신흥 지역에서의 시장 확장 등 기회 요소는 적극 활용되어야 합니다.

이 보고서의 주요 특징

• 본 보고서는 세계의 세포외 매트릭스 시장을 상세하게 분석하여 2024년을 기준 연도으로 한 예측기간(2025-2032년) 시장 규모 및 CAGR을 제공합니다.
• 또한 각 부문의 잠재적인 수익 기회를 밝혀 이 시장의 매력적인 투자 제안의 매트릭스에 대해 설명하고 있습니다.
• 또, 시장 성장 촉진요인 및 억제요인이나 기회, 신제품 출시 또는 승인, 시장 동향, 지역별 전망, 주요 기업이 채택하는 경쟁 전략 등에 관한 중요한 고찰도 제공합니다.
• 본 보고서의 통찰을 이용해, 마케팅 담당자나 기업의 경영진이, 장래의 제품 발매, 제휴, 시장 확대, 마케팅 전략에 관한, 충분한 정보에 근거한 의사 결정을 내릴 수 있습니다.
• '세계의 세포외 매트릭스 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 이 업계의 다양한 이해관계자에 대응하고 있습니다.
• 이해관계자는 세계의 세포외 매트릭스 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.

목차

제1장 분석 목적과 전제조건

• 분석 목적
• 전제조건
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의와 범위
• 주요 요약
• 일관된 기회 지도(COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
  • 성장 촉진요인
    • 만성 질환 증가
  • 억제요인
    • ECM 기반 치료법의 높은 비용
  • 기회
    • 혁신적인 ECM 기반 제품 개발
• 영향 분석
• 주요 하이라이트
• 규제 시나리오
• 제품 출시 및 승인
• PEST 분석
• Porter's Five Forces 분석
• 기업 합병 및 인수(M&A) 시나리오

제4장 세계의 세포외 매트릭스 시장 : COVID-19 팬데믹의 영향

• COVID-19의 역학
• 공급 측면 및 수요 측면 분석
• 경제에 미치는 영향

제5장 세계의 세포외 매트릭스 시장 : 컴포넌트 유형별(2020-2032년)

• 단백질
• 당단백질
• 프로테오글리칸
• 기타 ECM 분자

제6장 세계의 세포외 매트릭스 시장 : 용도별(2020-2032년)

• 재생 의료
• 조직 공학
• 상처 치유
• 약물 전달
• 암 연구
• 기타

제7장 세계의 세포외 매트릭스 시장 : 원료별(2020-2032년)

• 동물 유래 ECM
• 인간 유래 ECM
• 합성 ECM

제8장 세계의 세포외 매트릭스 시장 : 최종 사용자별(2020-2032년)

• 연구기관 및 학술센터
• 생명 공학 및 제약회사
• 병원 및 진료소

제9장 세계의 세포외 매트릭스 시장 : 제품 유형별(2020-2032년)

• 하이드로겔
• 스캐폴드
• 탈세포 ECM
• ECM 유사체
• 기타

제10장 세계의 세포외 매트릭스 시장 : 기술별(2020-2032년)

• 3D 바이오프린팅
• 나노기술
• 세포 배양 기술
• 유전자 공학
• 기타

제11장 세계의 세포외 매트릭스 시장 : 치료 영역별(2020-2032년)

• 정형외과
• 피부과
• 심장병학
• 신경학
• 종양학
• 기타

제12장 세계의 세포외 매트릭스 시장 : 기능별(2020-2032년)

• 구조적 지원
• 세포 통신
• 세포 접착
• 신호 전달

제13장 세계의 세포외 매트릭스 시장 : 생체 재료 유형별(2020-2032년)

• 천연 ECM
• 합성 ECM

제14장 세계의 세포외 매트릭스 시장 : 최종 이용 산업별(2020-2032년)

• 의료
• 연구 개발
• 화장품
• 의약품
• 기타

제15장 세계의 세포외 매트릭스 시장 : 지역별(2020-2032년)

• 북미
  • 미국
  • 캐나다
• 유럽
  • 영국
  • 독일
  • 이탈리아
  • 프랑스
  • 스페인
  • 러시아
  • 기타 유럽
• 아시아태평양
  • 중국
  • 인도
  • 일본
  • ASEAN
  • 호주
  • 한국
  • 기타 아시아태평양
• 라틴아메리카
  • 브라질
  • 멕시코
  • 아르헨티나
  • 기타 라틴아메리카
• 중동
  • GCC
  • 이스라엘
  • 기타 중동
• 아프리카
  • 북아프리카
  • 중앙 아프리카
  • 남아프리카

제16장 경쟁 구도

• Thermo Fisher Scientific
• DSM
• Acelity(KCI Concepts)
• Corning Incorporated
• Baxter
• FUJIFILM Holdings Corporation
• Integra LifeSciences
• CellSystems Biotechnologie Vertrieb GmbH
• Biotime, Inc.
• Trevigen, Inc.
• Advanced BioMatrix
• Collagen Matrix, Inc.
• Merck KGaA
• VWR International LLC
• REPROCELL USA Inc.
• BioLamina AB
• Matricel GmbH
• Tissue Regenix
• Admedus
• MIMETAS

제17장 섹션

• 분석 방법
• 회사 소개

HBR

영문 목차

영문목차

Extracellular Matrix Market is estimated to be valued at USD 44.2 Mn in 2025 and is expected to reach USD 74.8 Mn by 2032, growing at a compound annual growth rate (CAGR) of 7.8% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 44.2 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	7.80%	2032 Value Projection:	USD 74.8 Mn

Extracellular matrix (ECM) refers to the complex network of proteins and carbohydrates that provide structural support to cells within tissues and organs. It plays a crucial role in regulating cell behavior, including cell adhesion, migration, proliferation, and differentiation. The ECM also acts as a reservoir for growth factors and cytokines, influencing various cellular processes.

The global extracellular matrix market is witnessing significant growth due to the increasing prevalence of chronic diseases, rising demand for regenerative medicine, and advancements in tissue engineering. The market is driven by the growing aging population, which is more susceptible to chronic conditions such as cardiovascular diseases, orthopedic disorders, and skin ulcers. Additionally, the rising number of surgical procedures and the need for effective wound healing solutions are fueling the demand for ECM products.

However, the market faces challenges such as the high cost of ECM-based therapies, stringent regulatory requirements, and limited reimbursement policies. Moreover, the lack of awareness among healthcare professionals and patients about the benefits of ECM-based products hinders market growth.

Nevertheless, the market presents several opportunities for growth, including the development of innovative ECM-based products, collaborations between academic institutions and industry players, and the expansion of product portfolios in emerging markets. Furthermore, the increasing focus on personalized medicine and the integration of ECM technologies with other advanced therapies offer promising prospects for market expansion.

In conclusion, the global extracellular matrix market is poised for significant growth in the coming years, driven by the increasing prevalence of chronic diseases and the growing demand for regenerative medicine. However, challenges such as high costs and limited awareness need to be addressed to fully realize the market's potential.

Market Dynamics:

The global extracellular matrix market is driven by several factors, including the increasing prevalence of chronic diseases, advancements in tissue engineering, and the rising demand for regenerative medicine. The growing aging population, which is more susceptible to chronic conditions, is a key driver for market growth. Additionally, the rising number of surgical procedures and the need for effective wound healing solutions are fueling the demand for extracellular matrix products.

However, the market faces challenges such as the high cost of ECM-based therapies, stringent regulatory requirements, and limited reimbursement policies. The high cost of ECM-based therapies poses a significant barrier to market growth, limiting their accessibility to a larger patient population. Moreover, the stringent regulatory requirements for the approval of ECM-based products and the limited reimbursement policies in some regions hinder market expansion.

Despite these challenges, the market presents several opportunities for growth. The development of innovative ECM-based products, such as bioactive scaffolds and tissue-engineered constructs, holds immense potential for market expansion. Collaborations between academic institutions and industry players can further drive innovation and accelerate the development of advanced ECM technologies. Additionally, the expansion of product portfolios in emerging markets, where the demand for regenerative medicine is growing, can open up new avenues for market growth.

In conclusion, the global extracellular matrix market is driven by factors such as the increasing prevalence of chronic diseases and the rising demand for regenerative medicine. However, challenges such as high costs and regulatory requirements need to be addressed, while opportunities such as innovation and market expansion in emerging regions should be capitalized upon.

Key features of the study:

• This report provides in-depth analysis of the global extracellular matrix market, including market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), with 2024 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
• Key companies covered as a part of this study include Thermo Fisher Scientific, DSM, Acelity (KCI Concepts), Corning Incorporated, Baxter, FUJIFILM Holdings Corporation, Integra LifeSciences, CellSystems Biotechnologie Vertrieb GmbH, Biotime, Inc., Trevigen, Inc., Advanced BioMatrix, Collagen Matrix, Inc., Merck KGaA, VWR International LLC, REPROCELL USA Inc., BioLamina AB, Matricel GmbH, Tissue Regenix, Admedus, and MIMETAS.
• Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding their future product launches, type upgrades, market expansion, and marketing tactics.
• The global extracellular matrix market report caters to various stakeholders in this industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global extracellular matrix market.

Detailed Segmentation:

• Global Extracellular Matrix Market, By Component Type:
  • Proteins
  • Glycoproteins
  • Proteoglycans
  • Other ECM molecules
• Global Extracellular Matrix Market, By Application:
  • Regenerative Medicine
  • Tissue Engineering
  • Wound Healing
  • Drug Delivery
  • Cancer Research
  • Others
• Global Extracellular Matrix Market, By Source:
  • Animal-Derived ECM
  • Human-Derived ECM
  • Synthetic ECM
• Global Extracellular Matrix Market, By End-User:
  • Research Institutes and Academic Centers
  • Biotechnology and Pharmaceutical Companies
  • Hospitals and Clinics
• Global Extracellular Matrix Market, By Product Type:
  • Hydrogels
  • Scaffolds
  • Decellularized ECM
  • ECM Analogs
  • Others
• Global Extracellular Matrix Market, By Technology:
  • 3D Bioprinting
  • Nanotechnology
  • Cell Culture Techniques
  • Genetic Engineering
  • Others
• Global Extracellular Matrix Market, By Therapeutic Area:
  • Orthopedics
  • Dermatology
  • Cardiology
  • Neurology
  • Oncology
  • Others
• Global Extracellular Matrix Market, By Function:
  • Structural Support
  • Cellular Communication
  • Cell Adhesion
  • Signal Transduction
• Global Extracellular Matrix Market, By Biomaterial Type:
  • Natural ECM
  • Synthetic ECM
• Global Extracellular Matrix Market, By End-Use Industry:
  • Healthcare
  • Research and Development
  • Cosmetics
  • Pharmaceuticals
  • Others
• Global Extracellular Matrix Market, By By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
• Company Profiles:
  • Thermo Fisher Scientific
  • DSM
  • Acelity (KCI Concepts)
  • Corning Incorporated
  • Baxter
  • FUJIFILM Holdings Corporation
  • Integra LifeSciences
  • CellSystems Biotechnologie Vertrieb GmbH
  • Biotime, Inc.
  • Trevigen, Inc.
  • Advanced BioMatrix
  • Collagen Matrix, Inc.
  • Merck KGaA
  • VWR International LLC
  • REPROCELL USA Inc.
  • BioLamina AB
  • Matricel GmbH
  • Tissue Regenix
  • Admedus
  • MIMETAS

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Global Extracellular Matrix, By Component Type
  • Market Global Extracellular Matrix, By Application
  • Market Global Extracellular Matrix, By Source
  • Market Global Extracellular Matrix, By End-User
  • Market Global Extracellular Matrix, By Product Type
  • Market Global Extracellular Matrix, By Technology
  • Market Global Extracellular Matrix, By Therapeutic Area
  • Market Global Extracellular Matrix, By Function
  • Market Global Extracellular Matrix, By Biomaterial Type
  • Market Global Extracellular Matrix, By End-Use Industry
  • Market Global Extracellular Matrix, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
• The increasing prevalence of chronic diseases
  • Restraints
• High cost of ECM-based therapies
  • Opportunities
• Development of innovative ECM-based products
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Extracellular Matrix Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Extracellular Matrix Market, By Component Type, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2020 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Proteins
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Glycoproteins
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Proteoglycans
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Other ECM molecules
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Global Extracellular Matrix Market, By Application, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Regenerative Medicine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Tissue Engineering
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Wound Healing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Drug Delivery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Cancer Research
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

7. Global Extracellular Matrix Market, By Source, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Animal-Derived ECM
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Human-Derived ECM
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Synthetic ECM
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

8. Global Extracellular Matrix Market, By End-User, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Research Institutes and Academic Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Biotechnology and Pharmaceutical Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Hospitals and Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

9. Global Extracellular Matrix Market, By Product Type, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hydrogels
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Scaffolds
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Decellularized ECM
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• ECM Analogs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

10. Global Extracellular Matrix Market, By Technology, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• 3D Bioprinting
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Nanotechnology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Cell Culture Techniques
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Genetic Engineering
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

11. Global Extracellular Matrix Market, By Therapeutic Area, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Orthopedics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Dermatology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Cardiology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Neurology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Oncology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

12. Global Extracellular Matrix Market, By Function, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Structural Support
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Cellular Communication
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Cell Adhesion
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Signal Transduction
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

13. Global Extracellular Matrix Market, By Biomaterial Type, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Natural ECM
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Synthetic ECM
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

14. Global Extracellular Matrix Market, By End-Use Industry, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Healthcare
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Research and Development
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Cosmetics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Pharmaceuticals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

15. Global Extracellular Matrix Market, By Region, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, By Country, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Country 2021-2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Component Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End-User, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Function, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Biomaterial Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End-Use Industry, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Component Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End-User, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Function, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Biomaterial Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End-Use Industry, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Component Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End-User, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Function, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Biomaterial Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End-Use Industry, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Component Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End-User, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Function, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Biomaterial Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End-Use Industry, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Component Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End-User, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Function, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Biomaterial Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End-Use Industry, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Component Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End-User, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Function, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Biomaterial Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End-Use Industry, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
    • North Africa
    • Central Africa
    • South Africa

16. Competitive Landscape

• Thermo Fisher Scientific
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• DSM
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Acelity (KCI Concepts)
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Corning Incorporated
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Baxter
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• FUJIFILM Holdings Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Integra LifeSciences
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• CellSystems Biotechnologie Vertrieb GmbH
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Biotime, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Trevigen, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Advanced BioMatrix
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Collagen Matrix, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Merck KGaA
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• VWR International LLC
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• REPROCELL USA Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• BioLamina AB
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Matricel GmbH
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Tissue Regenix
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Admedus
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• MIMETAS
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

17. Section

• Research Methodology
• About us

관련자료